Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$631,121
New position
Shares Held
2,325
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#493
of 844 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in NTRA
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$2,035,875
PutShares
7,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026J. Goldman & Co LP holds $21,025,065 across 4 Diagnostics & Research names. NTRA ranks #4 (3.0% of the industry book) .
All Filings in NTRA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $631,121 | 2,325 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $2,035,875 | 7,500 | Put | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||